Eudragit nanoparticles containing genistein: formulation, development, and bioavailability assessment
Jingling Tang2, Na Xu1,2, Hongyu Ji1, Hongmei Liu1, Zhiyong Wang1, Linhua Wu1,2 1Department of Pharmacy, the Second Affiliated Hospital of Harbin Medical University, Key Laboratory of College in Heilongjiang Province; 2Department of Pharmaceutics, School of Pharmacy, Harbin Medical University, Harbi...
Guardado en:
Autores principales: | Tang J, Xu N, Ji H, Liu H, Wang Z, Wu L |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4f8e29591152443996e42a36a58090c7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cubic phase nanoparticles for sustained release of ibuprofen formulation characterization and enhanced bioavailability study
por: Dian L, et al.
Publicado: (2013) -
Enhanced bioavailability and efficiency of curcumin for the treatment of asthma by its formulation in solid lipid nanoparticles
por: Wang W, et al.
Publicado: (2012) -
Fabrication of genistein-loaded biodegradable TPGS-b-PCL nanoparticles for improved therapeutic effects in cervical cancer cells
por: Zhang H, et al.
Publicado: (2015) -
Factorial design applied to the optimization of lipid composition of topical antiherpetic nanoemulsions containing isoflavone genistein
por: Argenta DF, et al.
Publicado: (2014) -
Etoposide Amorphous Nanopowder for Improved Oral Bioavailability: Formulation Development, Optimization, in vitro and in vivo Evaluation
por: Wang Y, et al.
Publicado: (2020)